Orchestra BioMed (Nasdaq: OBIO) is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies. Orchestra BioMed’s partnership-enabled business model focuses on forging strategic collaborations with leading medical device companies to drive successful global commercialization of products it develops. Under these collaborations, Orchestra BioMed advances its promising therapeutic solutions through late-stage clinical research and regulatory approvals, while its collaborators focus on leveraging their commercial expertise and existing infrastructure to bring these product candidates to global markets quickly and efficiently. Orchestra BioMed’s lead product candidate is atrioventricular interval modulation (AVIM) therapy (also known as BackBeat Cardiac Neuromodulation Therapy (CNT™)) for the treatment of hypertension, a significant risk factor for death worldwide. Orchestra BioMed is also developing Virtue® Sirolimus AngioInfusion™ Balloon (SAB) for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. Orchestra BioMed has a strategic collaboration with Medtronic, one of the largest medical device companies in the world, for development and commercialization of AVIM therapy for the treatment of hypertension in pacemaker-indicated patients, and a strategic partnership with Terumo, a global leader in medical technology, for development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed has additional product candidates and plans to potentially expand its product pipeline through acquisitions, strategic collaborations, licensing and organic development. For further information about Orchestra BioMed, please visit www.orchestrabiomed.com.
View Top Employees from Orchestra BioMedWebsite | https://www.orchestrabiomed.com |
Revenue | $5 million |
Funding | $95 million |
Employees | 63 (51 on RocketReach) |
Founded | 2017 |
Address | 150 Union Square Dr, New Hope, Pennsylvania 18938, US |
Phone | (917) 254-4900 |
Technologies |
JavaScript,
HTML,
Twitter
+14 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Medical, Health Care |
SIC | SIC Code 384 Companies, SIC Code 38 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541711 Companies, NAICS Code 5417 Companies |
Looking for a particular Orchestra BioMed employee's phone or email?
The Orchestra BioMed annual revenue was $5 million in 2024.
CMCCP j.c. Simeon is the Senior Vice President of Quality of Orchestra BioMed.
51 people are employed at Orchestra BioMed.
Orchestra BioMed is based in New Hope, Pennsylvania.
The NAICS codes for Orchestra BioMed are [541, 54171, 54, 541711, 5417].
The SIC codes for Orchestra BioMed are [384, 38].